Explain the mechanism of acute respiratory distress syndrome
Reading Document
Medical Text Search
acute respiratory distress syndrome pathophysiology mechanism
Medical Text Search
ARDS diffuse alveolar damage inflammation cytokines endothelial injury
Medical Image Search
ARDS diffuse alveolar damage pathophysiology diagram
GradeResponse
GradeResponse
GradeResponse
Here is a comprehensive breakdown of the mechanism of ARDS.
Acute Respiratory Distress Syndrome (ARDS) — Mechanism
Overview
ARDS is a clinical-pathological syndrome characterized by three core physiological derangements (ARDS: Definition, Phenotyping and Respiratory Support Strategies, p. 2):
- Increased alveolo-capillary membrane permeability → inflammatory pulmonary edema
- Increased non-aerated lung tissue → reduced compliance (high lung elastance)
- Increased venous admixture and dead space → hypoxemia and hypercapnia
The underlying histological pattern is diffuse alveolar damage (DAD), which evolves through three overlapping phases.
The Three Phases of ARDS
Phase 1: Exudative Phase (Days 1–7)
This is the acute inflammatory phase and the core of ARDS pathogenesis (Harrison's Principles of Internal Medicine, 21st ed., p. 8197):
Cellular injury:
- Alveolar capillary endothelial cells and type I pneumocytes are the primary targets of injury
- Their destruction breaks down the normally tight alveolar-capillary barrier
Fluid and protein leak:
- Loss of barrier integrity allows protein-rich edema fluid to flood the interstitial and alveolar spaces
- This impairs gas exchange across the alveolar membrane
Cytokine storm and neutrophil recruitment:
- Proinflammatory cytokines are massively upregulated:
- IL-1, IL-8 — potent neutrophil chemoattractants
- TNF-α — promotes endothelial activation and permeability
- Leukotriene B₄ — lipid mediator amplifying neutrophil influx
- Neutrophils flood the pulmonary interstitium and alveoli, releasing:
- Reactive oxygen species (ROS)
- Myeloperoxidase (MPO)
- Neutrophil extracellular traps (NETs)
- Proteases — all causing further tissue destruction
Hyaline membrane formation:
- Condensed plasma proteins, cellular debris, and dysfunctional surfactant aggregate to form hyaline membrane whorls lining the alveolar walls — a hallmark of DAD on histology
Vascular injury:
- Pulmonary microvascular injury causes microthrombi and fibrocellular proliferation, obliterating the pulmonary vasculature and increasing dead space
Molecular Cascade Diagram
The diagram above shows how viral/infectious triggers activate macrophages (M1 phenotype) via TLR/PRR pathways → Th17 upregulation + T-reg suppression → cytokine release (TNF-α, IL-1, IL-6) → endothelial activation + platelet-neutrophil complex formation → ROS/MPO/NETs → diffuse alveolar damage + hyaline membranes.
Phase 2: Proliferative Phase (Days 7–21)
- Type II pneumocytes proliferate to replace destroyed type I cells and attempt barrier repair
- Continued inflammation drives fibroblast recruitment into the alveolar space
- Surfactant dysfunction persists — type II cells produce abnormal surfactant, worsening alveolar instability and collapse
- Organization of the fibrinous exudate begins
Phase 3: Fibrotic Phase (>21 days, in some patients)
- Some patients develop pulmonary fibrosis with obliteration of normal lung architecture
- Ongoing fibrocellular proliferation fills alveoli and interstitium
- Associated with prolonged ventilator dependence and poor prognosis
- Not all patients progress to this phase — resolution can occur after the proliferative phase
Pathophysiological Consequences
| Mechanism | Consequence |
|---|---|
| Alveolar flooding with protein-rich edema | Impaired O₂ diffusion → hypoxemia |
| Surfactant destruction/dysfunction | Alveolar collapse (atelectasis) → intrapulmonary shunt |
| Microthrombi and vascular obliteration | Increased dead space → hypercapnia |
| Reduced lung compliance | High work of breathing, ventilatory failure |
| Neutrophil-mediated oxidative injury | Further tissue necrosis, delayed repair |
| Non-uniform lung involvement ("baby lung") | Ventilator-induced lung injury (VILI) risk in dependent zones |
Triggers (Direct vs. Indirect)
| Direct (Pulmonary) | Indirect (Extrapulmonary) |
|---|---|
| Pneumonia (bacterial, viral, fungal) | Sepsis (most common overall cause) |
| Aspiration of gastric contents | Severe trauma / polytrauma |
| Inhalation injury / toxic gases | Massive blood transfusion (TRALI) |
| Lung contusion | Pancreatitis |
| Near-drowning | Burns |
In direct ARDS, the primary injury targets the alveolar epithelium. In indirect ARDS (e.g., sepsis), systemic inflammatory mediators reach the lung via the bloodstream, injuring the endothelium first — but the downstream cascade converges on the same DAD pattern.
Key Physiological Marker
PaO₂/FiO₂ ratio (P/F ratio) quantifies the severity of gas exchange impairment and drives the Berlin Definition staging:
| Severity | P/F Ratio |
|---|---|
| Mild | 200–300 mmHg |
| Moderate | 100–200 mmHg |
| Severe | <100 mmHg |
In summary, ARDS is a dysregulated innate immune response causing catastrophic breakdown of the alveolar-capillary barrier. The core sequence is: triggering insult → endothelial/epithelial injury → neutrophil-mediated inflammation → alveolar flooding + surfactant failure → severe hypoxemia — culminating in the histological pattern of diffuse alveolar damage.
This is a shared conversation. Sign in to Orris to start your own chat.